Buprenorphine versus domperidone in chemotherapy-induced emesis: A pilot study
- 1 June 1986
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 6 (2) , 127-133
- https://doi.org/10.1016/s0167-8140(86)80019-6
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- TWO SUDDEN DEATHS DURING PROPHYLACTIC ANTIEMETIC TREATMENT WITH HIGH DOSES OF DOMPERIDONE AND METHYLPREDNISOLONEThe Lancet, 1984
- Antiemetic Efficacy of DexamethasoneNew England Journal of Medicine, 1984
- Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study.Journal of Clinical Oncology, 1984
- SUDDEN DEATH IN CANCER PATIENT ON HIGH-DOSE DOMPERIDONEThe Lancet, 1982
- CYTOTOXIC-THERAPY-INDUCED VOMITING IS MEDIATED VIA ENKEPHALIN PATHWAYSThe Lancet, 1982
- Anticipatory Nausea and Vomiting with ChemotherapyNew England Journal of Medicine, 1982
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- Superiority of Nabilone over Prochlorperazine as an Antiemetic in Patients Receiving Cancer ChemotherapyNew England Journal of Medicine, 1979
- BuprenorphineDrugs, 1979
- Cytostatic-associated vomiting effectively inhibited by domperidone (R 33 812)Cancer Chemotherapy and Pharmacology, 1978